|
시장보고서
상품코드
2078219
바이오마커 시장 : 제품 종류별, 용도별, 적응증별, 최종사용자별, 지역별 : 시장 규모, 점유율, 전망, 기회 분석(2025-2032년)Biomarkers Market, By Product Type, By Application, By Disease Indication, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032 |
||||||
바이오마커 시장은 2026년에 927억 5,000만 달러 규모에 달할 것으로 추정되며, 2033년까지 2,292억 4,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 13.8%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 927억 5,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 13.80% | 예측 금액(2033년) | 2,292억 4,000만 달러 |
바이오마커란 생물학적 상태나 상황을 정량적으로 나타내는 지표를 말합니다. 전형적인 생물학적 과정, 병원성 과정 또는 치료적 개입에 대한 약리학적 반응을 조사하기 위해 혈액, 소변 또는 연조직을 이용한 바이오마커 검사 및 연구가 빈번하게 수행되고 있습니다. 많은 과학 분야에서 바이오마커가 활용되고 있습니다. 시장에서 적극적으로 활용되고 있는 바이오마커에는 ‘바이오마커 검사 키트’와 ‘바이오마커 분석 장치’의 두 가지 종류가 있습니다. 임상 용도별로 분류된 비교적 새로운 일련의 임상 도구 세트에는 의료 업계에서 사용되는 바이오마커가 포함되어 있습니다.
시장 역학
시장 참여자들의 신제품 출시 증가가 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2021년 4월 19일, 과학과 혁신을 활용하여 참신한 개념과 의학적 발견을 생명을 위협하는 질환을 앓고 있는 환자들의 치료로 연결하는 세계적인 생명공학 기업인 암젠(Amgen)은, 전이성(4기) 비소세포폐암(NSCLC) 환자에게 바이오마커 검사 접근성을 제공하기 위한 '바이오마커 어시스트' 프로그램의 시작을 발표했습니다. 환자를 적절한 치료 과정으로 이끄는 데 있어 중요한 첫걸음은 진단 시의 바이오마커 검사입니다. 해당 환자는 'Biomarker Assist'를 통해 바이오마커 검사 할인 혜택을 받을 수 있습니다.
또한, 2022년 2월 28일에는 국립보건연구원재단(FNIH) 바이오마커 컨소시엄이 주관하는 이니셔티브 프로그램이 시작되었습니다. 이 프로그램은 희귀 신경퇴행성 질환의 조기 발견에 필수적인 단백질을 평가하기 위한 가장 효과적인 혈액 검사를 규명하는 것을 목적으로 합니다. '가족성 전두측두형 치매(FTD)에서 신경퇴행의 체액 바이오마커로서의 뉴로필라멘트' 이 조사에서는 뉴로필라멘트로 알려진 이 단백질을 대상으로 한 하나 이상의 혈액 검사가, 유전적 및 가족적 요인에 의한 전두측두형 치매(FTD) 위험이 있는 개인을 식별하는 데 활용될 수 있음을 입증할 예정입니다. 이는 전두측두형 치매(FTD)를 보다 정확하게 예측하기 위한 신뢰성이 높고 비용이 저렴하며 비침습적인 방법을 개발하는 데 있어 매우 중요한 첫걸음이 될 것입니다. 또한, 위험군에 속하는 분들은 신약 임상시험에 참여할 수 있으며, 이는 궁극적으로 치료법 개발로 이어집니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 바이오마커 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 소개하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 바이오마커 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 바이오마커 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 바이오마커 시장 : 종류별(2021-2033년)
제5장 세계의 바이오마커 시장 : 용도별(2021-2033년)
제6장 세계의 바이오마커 시장 : 적응증별(2021-2033년)
제7장 세계의 바이오마커 시장 : 최종사용자별(2021-2033년)
제8장 세계의 바이오마커 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSM 26.07.14Biomarkers Market is estimated to be valued at USD 92.75 Bn in 2026 and is expected to reach USD 229.24 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 92.75 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.80% | 2033 Value Projection: | USD 229.24 Bn |
A biomarker is a quantifiable sign of a biological condition or state. In order to investigate typical biological processes, pathogenic processes, or pharmacologic reactions to a therapeutic intervention, biomarkers are frequently examined and studied utilizing blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical toolsets organized by clinical applications includes biomarkers utilized in the medical industry.
Market Dynamics
Increasing product launch by market players is expected to drive the market growth over the forecast period. For instance, on April 19, 2021, Amgen Inc., a global biotechnology company that uses science and innovation to translate novel concepts and medical discoveries into treatments for patients with life-threatening illnesses, announced the launch of the Biomarker Assist program, which aims to provide access to biomarker testing for patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker Assist.
Furthermore, on February 28, 2022, an initiative program was launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium aims to find the most effective blood tests for assessing a protein that is crucial for the early detection of rare neurodegenerative illnesses. The Neurofilament as a Fluid Biomarker of Neuro degeneration in Familial Front temporal Degeneration (FTD) study will demonstrate that one or more blood tests for this protein, known as neurofilament, can be used to determine individuals at risk of Front temporal Degeneration (FTD) due to genetic and familial ties. This is a crucial first step in developing a trustworthy, affordable, and non-invasive method to more accurately predict Front temporal Degeneration (FTD). Also, those who are at threat can take part in clinical studies of novel specifics, eventually leading to the development of treatments.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Acobiom, Apis Assay Technologies Ltd., Eagle Biosciences, Inc., Beckman Coulter, Inc., PerkinElmer Inc., Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc., Abnova Corporation, and Abbexa
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global biomarkers market
Detailed Segmentation:
- Global Biomarkers Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Biomarker Test Kits
- Biomarker Analyzer
- Global Biomarkers Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Biomarkers
- Monitoring Biomarkers
- Drug Discovery And Development
- Predictive Biomarkers
- Prognostic Biomarkers
- Global Biomarkers Market, By Disease Indication (Revenue, USD Bn, 2021 - 2033)
- Cancer
- Cardiovascular Disease
- Neurological Disorder
- Infectious disease
- Others (Immunological Disorder, and Autoimmune Disorders among others )
- Global Biomarkers Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Research and Academic Institute
- Global Biomarkers market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
- Company Profiles
- Agilent Technologies, Inc. *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F.Hoffmann-La Roche Ltd.
- Acobiom
- Apis Assay Technologies Ltd.
- Eagle Biosciences, Inc.
- Beckman Coulter, Inc.
- PerkinElmer Inc.
- Biopanda Reagents Ltd
- Quanterix
- Secure Diagnostics Pvt. Ltd.
- BioVision Inc.
- Merck KGaA
- R&D Systems
- Life Diagnostics
- QuantaMatrix Inc.
- Nanjing Synthgene Medical Technology Co. Ltd
- LifeSpan BioSciences Inc
- Wako USA,
- BioLegend, Inc
- Abnova Corporation
- Abbexa
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Disease Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Recent Product Approval/Launches
- PEST Analysis
- Porter's Analysis
4. Global Biomarkers Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biomarker Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Biomarker Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Biomarkers Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Monitoring Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Drug discovery and development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Predictive Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Prognostic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Biomarkers Market, By Disease Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Neurological Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Infectious disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others (Immunological Disorder, and Autoimmune Disorders among others )
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Biomarkers Market, End User, 2021 - 2033 (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Regional Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Bn)
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021- 2033, (US$ Bn)
- Research and Academic Institute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Global Biomarkers Market, By Region, 2021 - 2033 (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Regional Trends
- North America
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Bn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F.Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Acobiom
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Apis Assay Technologies Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eagle Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biopanda Reagents Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Quanterix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Secure Diagnostics Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioVision Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- R&D Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Life Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QuantaMatrix Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nanjing Synthgene Medical Technology Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- LifeSpan BioSciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Wako USA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioLegend, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbexa
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Analyst Views
10. Section
- Research Methodology
- About Us
